ADI vs AKAM Stock Comparison
Scores Breakdown
| Metric | ADI | AKAM |
|---|---|---|
| 📈 Growth | 28/30 | 22/30 |
| 💰 Profitability | 18/20 | 17/20 |
| 🏦 Financial Health | 18/20 | 17/20 |
| 💵 Valuation | 14/20 | 16/20 |
| ⚠️ Risk (lower is better) | 5/10 | 4/10 |
| Overall Score | 83/100 | 78/100 |
Side-by-Side Summaries
| ADI Analysis | AKAM Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver the eight quarters, ADI demonstrates a clear uptrend in top-line and bottom-line. Revenues rose from about $2.44B in 2024 Q4 to about $4.02B in 2026 Q3, a roughly 64% expansion. Net income to parent grew from about $478M in 2024 Q4 to about $1.34B in 2026 Q3, despite a dip in 2025 Q1, indicating improving profitability and operating leverage. The sequence shows steady quarterly progression and resilience during 2025. 💰 Margins & Cash FlowGross margin runs in the mid-60s percent across quarters, supporting sustainable returns as revenue scales. Operating income remains robust, with healthy leverage by 2026 Q3. Cash flow from operating activities stayed positive across the period (e.g., around $1.6B in several quarters) even as investing/financing cash flows varied; free cash flow is generally supported by earnings. 🛡️ Balance Sheet & LiquidityBalance sheet is robust: Equity around $33–35B and total assets near $48B, with liabilities around $14B, implying conservative leverage. Current ratio fluctuates above 1, signaling solid liquidity. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver the 8 quarters, AKAM's revenues rose from about $1.00B to about $1.10B, a modest expansion of ~9-10%, with a steady uptrend across quarters. Net income moved from roughly $58M in 2024-Q3 to a peak of about $140M in 2025-Q3, before printing around $79M in 2026-Q2, reflecting quarterly volatility but positive trajectory. 💰 Margins & Cash FlowGross margin stayed robust in the mid-to-high 50s% (Q2 2026 ~55.8%; Q4 2025 ~58.6%; Q3 2025 ~59.2%). Operating income remained positive in every quarter shown. Operating cash flow (continuing) was solid, e.g., around $326M in 2026-Q2. Net cash flow turned positive in 2026-Q2 at roughly $0.85B, with investing cash outflows offset by financing inflows in several quarters, indicating healthy cash generation despite capex. 🛡️ Balance Sheet & LiquidityAssets near $15.1B in 2026-Q2, liabilities around $10.3B, and equity about $4.75B. Current assets vs current liabilities yield a comfortable liquidity cushion (approx. 1.6x). Leverage remains moderate with substantial noncurrent assets and conservative equity backing. ⚠️ Key Drivers & Risks
|